Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

Xeltis United Kingdom United States of America Netherlands

Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysisaXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vesselView original content:https://www.prnewswire.co.uk/news-releases/xeltis-announces-latest-results-from-axess-trials-to-be-presented-at-46th-annual-charing-cross-symposium-302118528.html